用依库珠单抗成功治疗灾难性抗磷脂综合征过程中的血栓性微血管病：病例报告及文献系统综述 - Suppr | 超能文献

相似文献

1

Thrombotic microangiopathy in the course of catastrophic antiphospholipid syndrome successfully treated with eculizumab: case report and systematic review of the literature.用依库珠单抗成功治疗灾难性抗磷脂综合征过程中的血栓性微血管病：病例报告及文献系统综述

Lupus. 2020 May;29(6):631-639. doi: 10.1177/0961203320917460. Epub 2020 Apr 6.

2

Secondary thrombotic microangiopathy in systemic lupus erythematosus and antiphospholipid syndrome, the role of complement and use of eculizumab: Case series and review of literature.系统性红斑狼疮和抗磷脂综合征中的继发性血栓性微血管病、补体的作用及依库珠单抗的应用：病例系列及文献复习。

Semin Arthritis Rheum. 2019 Aug;49(1):74-83. doi: 10.1016/j.semarthrit.2018.11.005. Epub 2018 Dec 4.

3

Thrombotic microangiopathy due to primary antiphospholipid syndrome: successful treatment with eculizumab.原发性抗磷脂综合征相关血栓性微血管病：依库珠单抗治疗成功。

J Nephrol. 2024 May;37(4):1141-1145. doi: 10.1007/s40620-023-01789-4. Epub 2023 Oct 17.

4

A systematic review of the role of eculizumab in systemic lupus erythematosus-associated thrombotic microangiopathy.系统性红斑狼疮相关性血栓性微血管病中依库珠单抗作用的系统评价。

BMC Nephrol. 2020 Jun 30;21(1):245. doi: 10.1186/s12882-020-01888-5.

5

A case of thrombotic microangiopathy associated with antiphospholipid antibody syndrome successfully treated with eculizumab.1例抗磷脂抗体综合征相关血栓性微血管病经依库珠单抗治疗成功

Transplantation. 2014 Aug 15;98(3):e17-8. doi: 10.1097/TP.0000000000000267.

6

Case report: Timing of eculizumab treatment in catastrophic antiphospholipid syndrome.病例报告：卡塔性抗磷脂综合征中依库珠单抗治疗的时机。

Front Immunol. 2024 Sep 10;15:1460317. doi: 10.3389/fimmu.2024.1460317. eCollection 2024.

7

Use of eculizumab in a systemic lupus erythemathosus patient presenting thrombotic microangiopathy and heterozygous deletion in CFHR1-CFHR3. A case report and systematic review.依库珠单抗在系统性红斑狼疮伴血栓性微血管病及 CFHR1-CFHR3 杂合缺失患者中的应用：病例报告及系统评价。

Clin Rheumatol. 2017 Dec;36(12):2859-2867. doi: 10.1007/s10067-017-3823-2. Epub 2017 Sep 13.

8

Thrombotic microangiopathy in systemic lupus erythematosus: efficacy of eculizumab.系统性红斑狼疮中的血栓性微血管病：依库珠单抗的疗效。

Am J Kidney Dis. 2015 Jan;65(1):127-30. doi: 10.1053/j.ajkd.2014.07.031. Epub 2014 Nov 15.

9

Complement inhibition with eculizumab for thrombotic microangiopathy rescues a living-donor kidney transplant in a patient with antiphospholipid antibody syndrome.使用依库珠单抗抑制补体治疗血栓性微血管病挽救了一名抗磷脂抗体综合征患者的活体供肾移植。

Transfus Apher Sci. 2017 Jun;56(3):400-403. doi: 10.1016/j.transci.2017.02.007. Epub 2017 Mar 10.

10

Primary antiphospholipid syndrome presented as thrombotic microangiopathy in renal transplantation.原发性抗磷脂综合征在肾移植中表现为血栓性微血管病。

Nefrologia (Engl Ed). 2020 Jan-Feb;40(1):108-110. doi: 10.1016/j.nefro.2019.06.001. Epub 2019 Aug 17.

引用本文的文献

1

Case report: Timing of eculizumab treatment in catastrophic antiphospholipid syndrome.病例报告：卡塔性抗磷脂综合征中依库珠单抗治疗的时机。

Front Immunol. 2024 Sep 10;15:1460317. doi: 10.3389/fimmu.2024.1460317. eCollection 2024.

2

Complement biomarkers in the antiphospholipid syndrome - Approaches to quantification and implications for clinical management.抗磷脂综合征中的补体生物标志物——定量方法及对临床管理的影响。

Clin Immunol. 2023 Dec;257:109828. doi: 10.1016/j.clim.2023.109828. Epub 2023 Oct 31.

3

An update on the biologics for the treatment of antiphospholipid syndrome.